248 related articles for article (PubMed ID: 19665031)
1. Ligand entry and exit pathways in the beta2-adrenergic receptor.
Wang T; Duan Y
J Mol Biol; 2009 Oct; 392(4):1102-15. PubMed ID: 19665031
[TBL] [Abstract][Full Text] [Related]
2. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
3. Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists.
Isogaya M; Sugimoto Y; Tanimura R; Tanaka R; Kikkawa H; Nagao T; Kurose H
Mol Pharmacol; 1999 Nov; 56(5):875-85. PubMed ID: 10531390
[TBL] [Abstract][Full Text] [Related]
4. Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor.
Chen Y; Fleetwood O; Pérez-Conesa S; Delemotte L
J Chem Inf Model; 2021 Dec; 61(12):6024-6037. PubMed ID: 34780174
[TBL] [Abstract][Full Text] [Related]
5. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors.
Emtage AL; Mistry SN; Fischer PM; Kellam B; Laughton CA
J Biomol Struct Dyn; 2017 Sep; 35(12):2604-2619. PubMed ID: 27532213
[TBL] [Abstract][Full Text] [Related]
6. FoldGPCR: structure prediction protocol for the transmembrane domain of G protein-coupled receptors from class A.
Michino M; Chen J; Stevens RC; Brooks CL
Proteins; 2010 Aug; 78(10):2189-201. PubMed ID: 20544957
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
Huber T; Menon S; Sakmar TP
Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
[TBL] [Abstract][Full Text] [Related]
8. Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.
Reynolds KA; Katritch V; Abagyan R
J Comput Aided Mol Des; 2009 May; 23(5):273-88. PubMed ID: 19148767
[TBL] [Abstract][Full Text] [Related]
9. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.
Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R
J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579
[TBL] [Abstract][Full Text] [Related]
10. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
Rosenbaum DM; Cherezov V; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Yao XJ; Weis WI; Stevens RC; Kobilka BK
Science; 2007 Nov; 318(5854):1266-73. PubMed ID: 17962519
[TBL] [Abstract][Full Text] [Related]
11. Retinal release from opsin in molecular dynamics simulations.
Wang T; Duan Y
J Mol Recognit; 2011; 24(2):350-8. PubMed ID: 21360617
[TBL] [Abstract][Full Text] [Related]
12. On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor.
Costanzi S
J Med Chem; 2008 May; 51(10):2907-14. PubMed ID: 18442228
[TBL] [Abstract][Full Text] [Related]
13. Agonist binding by the β2-adrenergic receptor: an effect of receptor conformation on ligand association-dissociation characteristics.
Plazinska A; Plazinski W; Jozwiak K
Eur Biophys J; 2015 Apr; 44(3):149-63. PubMed ID: 25726162
[TBL] [Abstract][Full Text] [Related]
14. Ligand-binding affinity of alternative conformers of human β
Dilcan G; Doruker P; Akten ED
Chem Biol Drug Des; 2019 May; 93(5):883-899. PubMed ID: 30637937
[TBL] [Abstract][Full Text] [Related]
15. Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor.
Bokoch MP; Zou Y; Rasmussen SG; Liu CW; Nygaard R; Rosenbaum DM; Fung JJ; Choi HJ; Thian FS; Kobilka TS; Puglisi JD; Weis WI; Pardo L; Prosser RS; Mueller L; Kobilka BK
Nature; 2010 Jan; 463(7277):108-12. PubMed ID: 20054398
[TBL] [Abstract][Full Text] [Related]
16. Identifying ligand binding conformations of the β2-adrenergic receptor by using its agonists as computational probes.
Isin B; Estiu G; Wiest O; Oltvai ZN
PLoS One; 2012; 7(12):e50186. PubMed ID: 23300522
[TBL] [Abstract][Full Text] [Related]
17. Investigation of allosteric coupling in human β2-adrenergic receptor in the presence of intracellular loop 3.
Ozgur C; Doruker P; Akten ED
BMC Struct Biol; 2016 Jul; 16(1):9. PubMed ID: 27368374
[TBL] [Abstract][Full Text] [Related]
18. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.
Cherezov V; Rosenbaum DM; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Kuhn P; Weis WI; Kobilka BK; Stevens RC
Science; 2007 Nov; 318(5854):1258-65. PubMed ID: 17962520
[TBL] [Abstract][Full Text] [Related]
19. Predicted 3D structure for the human beta 2 adrenergic receptor and its binding site for agonists and antagonists.
Freddolino PL; Kalani MY; Vaidehi N; Floriano WB; Hall SE; Trabanino RJ; Kam VW; Goddard WA
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):2736-41. PubMed ID: 14981238
[TBL] [Abstract][Full Text] [Related]
20. Comparison of dynamics of extracellular accesses to the β(1) and β(2) adrenoceptors binding sites uncovers the potential of kinetic basis of antagonist selectivity.
Selvam B; Wereszczynski J; Tikhonova IG
Chem Biol Drug Des; 2012 Aug; 80(2):215-26. PubMed ID: 22530954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
